Bora Pharmaceuticals Co., LTD.

Informe acción TWSE:6472

Capitalización de mercado: NT$80.2b

Bora Pharmaceuticals Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Bobby Sheng

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO10.3yrs
Participación del CEO6.7%
Permanencia media de la dirección7.2yrs
Promedio de permanencia en la Junta Directiva8.5yrs

Actualizaciones recientes de la dirección

Recent updates

Bora Pharmaceuticals' (TWSE:6472) Earnings Are Weaker Than They Seem

Nov 21
Bora Pharmaceuticals' (TWSE:6472) Earnings Are Weaker Than They Seem

Does Bora Pharmaceuticals (TWSE:6472) Deserve A Spot On Your Watchlist?

Oct 04
Does Bora Pharmaceuticals (TWSE:6472) Deserve A Spot On Your Watchlist?

Investors Appear Satisfied With Bora Pharmaceuticals Co., LTD.'s (TWSE:6472) Prospects

Jul 18
Investors Appear Satisfied With Bora Pharmaceuticals Co., LTD.'s (TWSE:6472) Prospects

Is Bora Pharmaceuticals Co., LTD. (TWSE:6472) Trading At A 44% Discount?

Jun 13
Is Bora Pharmaceuticals Co., LTD. (TWSE:6472) Trading At A 44% Discount?

Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Apr 10
Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt

Apr 08
Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt

Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality

Mar 14
Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality

Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?

Apr 30
Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?

Mar 17
Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?

Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment

Feb 17
Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment

New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)

Jan 27
New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)

Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt

Jan 19
Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt

We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings

Dec 29
We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings

Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?

Dec 09
Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?

CEO

Bobby Sheng

10.3yrs

Permanencia

Mr. Pao-Shi Sheng, also known as Bobby, serves as Chairman of the Board at SunWay Biotech Co. LTD. since 2024. He Founder of Earth 88 and serves as its Chief Executive Officer.He serves as an Independent...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Pao-Shi Sheng
Chairmanno datasin datos6.72%
NT$ 5.4b
Alice Wang
CFO of HQ & APAC11.8yrssin datossin datos
Ellen Chen
Corporate Human Resource Director2.8yrssin datossin datos
Shih-Min Chen
VP & Director11.6yrssin datos1.04%
NT$ 834.2m
Sally Langa
Senior VP of Marketing and Sales - CDMO Businessno datasin datossin datos
Marcel Vieno
CFO of North Americano datasin datossin datos
Tom Chang
Senior Vice President of Taiwan Site Operations1.8yrssin datossin datos
Xiu-Rong Zhang
Deputy General Managerno datasin datos0.0099%
NT$ 8.0m
Zhen-Tang Zhang
Deputy General Managerno datasin datos0.067%
NT$ 54.1m

7.2yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de 6472 es experimentado (7.2 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Pao-Shi Sheng
Chairman10.3yrssin datos6.72%
NT$ 5.4b
Shih-Min Chen
VP & Director10.3yrssin datos1.04%
NT$ 834.2m
Jui-Yi Lin
Independent Director9.6yrssin datossin datos
Shang-Hung Shen
Director10.3yrssin datossin datos
Kuan-Pai Chen
Director5.4yrssin datossin datos
Ming-Jung Lai
Independent Director7.4yrssin datossin datos
Yi-Chin Lee
Independent Director7.4yrssin datos0.028%
NT$ 22.8m
Hsin-I Lin
Independent Director1.4yrssin datos0%
NT$ 0

8.5yrs

Permanencia media

Junta con experiencia: La junta directiva de 6472 se considera experimentada (8.5 años de antigüedad promedio).